TrialThe British journal of ophthalmology2025

Impact of retinal thickness fluctuations with ranibizumab versus aflibercept in neovascular age-related macular degeneration (SALT): 12-month results from a multicentre, randomised, phase IV trial.

Hansjuergen T Agostini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.